Sec Form 4 Filing - Perego Kenneth II @ One World Products, Inc. - 2024-07-25

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Perego Kenneth II 2. Issuer Name and Ticker or Trading Symbol One World Products, Inc. [ OWPC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 6605 GRAND MONTECITO PKWY., SUITE 100 3. Date of Earliest Transaction (MM/DD/YY) 07/25/2024 (Street) LAS VEGAS, NV89149 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 7,000,000 I See footnote ( 5 ) Common Stock 5,785,000 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series A Preferred Stock ( 1 ) 07/25/2024 A 15,000 07/25/2024 ( 1 ) Common Stock 1,500,000 $ 150,000 ( 1 ) ( 2 ) ( 6 ) 2,600,000 ( 7 ) I See footnote ( 4 ) Warrants to Purchase Common Stock $ 0.25 07/25/2024 A 1,500,000 07/25/2024 07/25/2029 Common Stock 1,500,000 $ 0 ( 1 ) ( 3 ) ( 6 ) 2,050,000 I See footnote ( 4 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Perego Kenneth II 6605 GRAND MONTECITO PKWY., SUITE 100 LAS VEGAS, NV89149 X Signatures /s/ Dr. Kenneth Perego, II, M.D. 08/22/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )15,000 shares of Series A Preferred Stock and a Warrant to Purchase Common Stock of the Issuer were purchased, in units, by the Reporting Person for $150,000 in cash. Each share of Series A Preferred Stock is convertible at any time, at the Reporting Person's election, into 100 shares of the Issuer's common stock and has no expiration date ( 2 )Each share of Series A Preferred Stock is convertible at any time, at the election of the Reporting Person, into 100 shares of common stock of the Issuer. ( 3 )The Warrant to Purchase Common Stock is exercisable at any time, at the election of the Reporting Person, at an exercise price of $0.25 per share. ( 4 )Owned of record by Perego Trust, of which the Reporting Person is Trustee. ( 5 )Owned of record by CB Medical, LLC, of which the Reporting Person is the owner. ( 6 )All of the purchase price was allocated to the shares of Series A Preferred Stock. ( 7 )The Reporting Person beneficially owns a total of 17,785,000 shares of common stock of the Issuer.

Remarks: This is a late Form 4 filing.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.